KMX SHAREHOLDER ALERT: BFA Law Notifies CarMax, Inc. Investors of Important January 2 Securities Class Action Deadline for Investors seeking RecoveryNovember 12, 2025 7:17 AM EST | Source: Bleichmar Fonti & AuldNew York, New York--(Newsfile Corp. - November 12, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CarMax, Inc. (NYSE: KMX) and certain of the Company's senior executives for securities fraud after a significant ...

INSP SHAREHOLDER ALERT: BFA Law Notifies Inspire Medical Systems, Inc. Investors of Important January 5 Securities Class Action Deadline for Investors seeking RecoveryNovember 12, 2025 7:17 AM EST | Source: Bleichmar Fonti & AuldNew York, New York--(Newsfile Corp. - November 12, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company's senior executives for ...

Core Viewpoint - Coty Inc. is under investigation for potential violations of federal securities laws, which may allow investors to recover losses due to misleading statements regarding product demand and inventory levels [1][3]. Company Overview - Coty Inc. is one of the largest beauty companies globally, with a diverse portfolio that includes fragrances, color cosmetics, and skin and body care products. Prestige fragrances represent 60% of the company's revenues [3]. Investigation Details - The investigation is prompted by discrepancies between Coty's claims about strong demand for Prestige fragrances and the reality of overstocked inventory at retailers, indicating a decline in demand for Coty's products [3]. Financial Performance - On August 20, 2025, Coty reported disappointing financial results for Q4 and FY 2025, citing issues such as delays in identifying weaknesses in U.S. execution, retailer inventory buildup, and challenges from previous fiscal year innovations. The company noted a slowdown in cosmetics sales due to various factors, including value-seeking behavior and U.S.-specific issues [4]. - Following the announcement of these results, Coty's stock price fell by $1.05, a decline of over 21%, from $4.86 to $3.81 per share within a day [4].

Core Viewpoint - Stride, Inc. is under investigation for potential securities fraud due to misleading statements about its performance and customer demand, which may have led to significant financial losses for investors [1][3][4]. Group 1: Company Performance and Issues - Stride, Inc. is an education technology company that claimed to experience "record demand" for its products and services during a specific period [3]. - Contrary to its claims, Stride faced severe backlash from customers due to unpopular platform changes, resulting in a poor customer experience and loss of students [4]. - The company reported a significant drop in growth rate attributed to poorly executed upgrades, leading to higher withdrawal rates and lower conversion rates [5]. Group 2: Financial Impact - On October 28, 2025, Stride disclosed that its growth rate did not meet expectations, estimating a loss of approximately 10,000-15,000 enrollments due to the negative impact of the platform changes [5]. - Following this announcement, Stride's stock price plummeted by $83.48 per share, a decline of over 54%, from $153.53 to $70.05 within a day [6].

Core Viewpoint - A class action lawsuit has been filed against Synopsys, Inc. for securities fraud following a significant stock drop due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - Investors have until December 30, 2025, to request to lead the case in the U.S. District Court for the Northern District of California [3]. - The lawsuit claims violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [3]. Group 2: Company Performance - Synopsys provides design automation software and has seen its Design IP segment grow from 25% of revenue in 2022 to 31% in 2024 [4]. - The company reported a revenue of $425.9 million for its Design IP segment in Q3 2025, reflecting a 7.7% year-over-year decline, and a net income of $242.5 million, down 43% year-over-year [6]. Group 3: Market Reaction - Following the release of disappointing Q3 2025 results, Synopsys stock fell nearly 36%, from $604.37 per share to $387.78 per share [6]. - The decline was attributed to customers requiring more customization for IP components, which negatively impacted the business model [5][6].

Core Viewpoint - The CarMax class action lawsuit alleges that the company and its executives misrepresented growth prospects, leading to significant stock price declines following disappointing financial results and executive termination announcements [3][4][5]. Group 1: Class Action Details - The class action lawsuit is titled Cap v. CarMax, Inc., and it involves purchasers of CarMax securities from June 20, 2025, to November 5, 2025 [1]. - Investors have until January 2, 2026, to seek appointment as lead plaintiff in the lawsuit [1][6]. - The lawsuit claims that CarMax overstated its growth due to temporary factors related to customer behavior influenced by tariff speculation [3]. Group 2: Financial Performance - CarMax reported a 5.4% decrease in retail unit sales and a 6.3% decrease in comparable store unit sales for the second quarter of fiscal year 2026 [4]. - Net earnings per diluted share fell to $0.64 from $0.85 a year ago, contributing to a 20% drop in share price following the announcement [4]. - On November 6, 2025, CarMax announced the termination of CEO William D. Nash and projected a significant decline in used car sales, resulting in a further 24% drop in share price [5]. Group 3: Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased CarMax securities during the class period to seek lead plaintiff status [6]. - The lead plaintiff represents the interests of all class members and can choose a law firm for litigation [6]. Group 4: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [7]. - The firm has a strong track record, including the largest securities class action recovery in history at $7.2 billion [7].

Core Viewpoint - A class action lawsuit has been filed against Stride, Inc. for allegedly misleading investors about its business prospects and inflating enrollment numbers through unethical practices [2][3]. Allegations Against Stride, Inc. - Stride, Inc. is accused of making false statements regarding its success and capabilities in the education technology sector, claiming to be a leading company while engaging in practices such as retaining "ghost students" to inflate enrollment figures [2]. - The company allegedly cut staffing costs by overloading teachers with excessive caseloads, ignored compliance requirements, and suppressed whistleblowers who reported financial misconduct [2]. - A complaint from the Gallup-McKinley County Schools Board of Education accused Stride of fraud and deceptive practices, leading to a significant drop in stock price following the news [3]. Impact on Stock Performance - Following the allegations, Stride's stock price fell by $18.60 per share (11.7%) on September 15, 2025, after the fraud allegations were reported [3]. - On October 28, 2025, Stride announced that poor customer experience led to a loss of 10,000-15,000 enrollments, resulting in a dramatic stock price drop of $83.48 per share (over 54%) to close at $70.05 on October 29, 2025 [4].

Core Viewpoint - Alector, Inc. is under investigation by the Schall Law Firm for potential violations of securities laws following disappointing results from a clinical trial, which led to a significant drop in its stock price [2][3]. Group 1: Investigation Details - The Schall Law Firm is investigating claims on behalf of Alector investors regarding false or misleading statements made by the company [2]. - Alector's press release on October 21, 2025, revealed that its drug candidate, latozinemab (AL001), failed to meet the primary endpoint in a Phase 3 clinical trial for frontotemporal dementia, resulting in a nearly 50% drop in share price the following day [2][3]. Group 2: Legal Representation - The Schall Law Firm specializes in securities class action lawsuits and is encouraging affected shareholders to participate in the investigation [3]. - Investors can contact the Schall Law Firm for a free discussion about their rights [3].

Core Viewpoint - A class action lawsuit has been filed against James Hardie Industries plc, alleging that the company misled investors regarding the performance of its North America Fiber Cement segment during the specified class period [3]. Group 1: Lawsuit Details - The lawsuit covers investors who purchased securities from May 20, 2025, to August 18, 2025, claiming that James Hardie falsely represented the strength of its North American operations despite knowledge of inventory destocking [3]. - On August 19, 2025, James Hardie reported a 12% decline in North American net sales for fiscal Q1 2026, attributing this to customers adjusting inventory levels, which was contrary to the company's previous claims [4]. - Following the earnings report, James Hardie's stock price fell by approximately 34.4%, from $28.43 to $18.64 per share [4]. Group 2: Investor Actions - Investors who suffered losses are encouraged to contact Kirby McInerney LLP to discuss their rights and potential participation in the class action lawsuit [1][6]. - The deadline for investors to request appointment as lead plaintiff is December 23, 2025 [1]. Group 3: Legal Firm Information - Kirby McInerney LLP specializes in securities litigation and has achieved significant recoveries for shareholders in the past [8]. - The firm is based in New York and focuses on various types of litigation, including antitrust and consumer cases [8].

Core Viewpoint - The Synopsys class action lawsuit alleges that the company and its executives violated the Securities Exchange Act of 1934, leading to significant financial losses for investors [1][3]. Company Overview - Synopsys, Inc. provides electronic design automation software products used for designing and testing integrated circuits, operating in two segments: Design Automation and Design IP [2]. Allegations of the Lawsuit - The lawsuit claims that Synopsys failed to disclose the negative impact of its increased focus on artificial intelligence customers on the economics of its Design IP business [3]. - It is alleged that certain decisions regarding road maps and resources were unlikely to yield intended results, which materially affected financial outcomes [3]. Financial Performance - On September 9, 2025, Synopsys reported third quarter 2025 financial results, revealing quarterly revenue of $1.740 billion, which was below the guidance of $1.755 billion to $1.785 billion [4]. - The net income for the quarter was $242.5 million, representing a 43% decline from $425.9 million in the same quarter of 2024 [4]. - The Design IP segment accounted for approximately 25% of revenue, totaling $426.6 million, a 7.7% year-over-year decline, with guidance indicating at least a 5% decline in full-year revenues for fiscal 2025 [4]. - Following the financial results announcement, Synopsys' stock price fell by nearly 36% [4].